D.E. Shaw & Co
IART icon

D.E. Shaw & Co’s Integra LifeSciences IART Stock Holding History

D.E. Shaw & Co’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-20,000
Closed -$893K – 4098
2020
Q1 		$893K Buy
+20,000
New +$1.05M ﹤0.01% 2819

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co's IART Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Integra LifeSciences (IART) stake by 17% in Q1 2026, selling an estimated $879K and leaving 389,499 shares worth $3.67M. The position accounts for ﹤0.01% of the portfolio, ranked #2408.

D.E. Shaw & Co first reported a position in IART in Q4 2013 and has held it in 49 quarters since. The position peaked at $33M in Q2 2018. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • D.E. Shaw & Co held 389,499 shares of Integra LifeSciences worth $3.67M as of Q1 2026.
  • D.E. Shaw & Co sold 80,098 Integra LifeSciences shares in Q1 2026, an estimated $879K.
  • Integra LifeSciences made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #2408 holding.
  • D.E. Shaw & Co first reported a position in Integra LifeSciences in Q4 2013 and has held it in 49 quarters since.
  • D.E. Shaw & Co's Integra LifeSciences position peaked at $33M in Q2 2018.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.